Benitec Biopharma Inc. (BNTC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 622.95M |
| Enterprise Value | 443.74M |
| P/E Ratio | -9.78 |
| PEG Ratio | -0.19 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.52 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.96 |
Fiscal Year
| Fiscal Year | June 30, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.25 |
| Return On Equity | -0.28 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -481,000 |
| EBITDA | -50.71M |
| Net Income | -45.55M |
| Diluted EPS | -0.98 |
Balance Sheet
| Total Cash | 179.97M |
| Total Cash/Share | 3.87 |
| Total Debt | 762,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 34 |
| Book Value Per Share | 3.8 |
Price History
| 52-Week Change | -31.62 |
| 52-Week High | 16.76 |
| 52-Week Low | 9.26 |
| Moving Average 50 Days | 11.99 |
| Moving Average 200 Days | 11.92 |
Statistics
| Average Volume | 142,039 |
| Shares Outstanding | 34.35M |
| % Held by Institutions | 67.25 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:17 |
| Last Split Date | July 26, 2023 |
AD
